Skip to main content
Erschienen in: Pediatric Cardiology 2/2013

01.02.2013 | Original Article

Do Predictors of Incomplete Kawasaki Disease Exist for Infants?

verfasst von: Sol Ji No, Dong Ouk Kim, Kyong Min Choi, Lucy Youngmin Eun

Erschienen in: Pediatric Cardiology | Ausgabe 2/2013

Einloggen, um Zugang zu erhalten

Abstract

Kawasaki disease (KD), an acute febrile vasculitis, is the most common cause of acquired heart disease in infants and young children. However, the diagnosis of infantile KD can be difficult or delayed due to vague clinical manifestations. This current study aimed to assess the clinical characteristics and cardiac complications of infantile KD. The study retrospectively reviewed the data of 242 patients with KD. The clinical, laboratory, and echocardiographic data between infants and older children were analyzed. The patients were divided into two groups: infants 12 months old or younger and children older than 12 months. The rate of incomplete KD was much more frequent in infants. During all phases, prohormone brain natriuretic peptide (Pro-BNP) levels were higher in infants, as was thrombocytosis. The coronary artery z-score was higher in infants at all phases of KD. On tissue Doppler imaging, the E/E′ ratio (ratio of transmitral Doppler early filling velocity to tissue Doppler early diastolic mitral annular velocity) was higher at the septal and lateral annulus in infants. Infant patients with KD are at increased risk for the development of coronary abnormalities and diastolic dysfunction. Higher levels of Pro-BNP and thrombocytosis with diastolic echo parameters of a higher E/E′ ratio can help to identify incomplete KD in infants.
Literatur
1.
Zurück zum Zitat Burns JC, Wiggens JW, Toews WH et al (1986) Clinical spectrum of Kawasaki disease in infants younger than 6 months of age. J Pediatr 109:759–763PubMedCrossRef Burns JC, Wiggens JW, Toews WH et al (1986) Clinical spectrum of Kawasaki disease in infants younger than 6 months of age. J Pediatr 109:759–763PubMedCrossRef
2.
Zurück zum Zitat Chang FY, Hwang B, Chen SJ, Lee PC, Meng CC, Lu JH (2006) Characteristics of Kawasaki disease in infants younger than six months of age. Pediatr Infect Dis J 25:241–244PubMedCrossRef Chang FY, Hwang B, Chen SJ, Lee PC, Meng CC, Lu JH (2006) Characteristics of Kawasaki disease in infants younger than six months of age. Pediatr Infect Dis J 25:241–244PubMedCrossRef
3.
Zurück zum Zitat Dahdah N, Siles A, Fournier A, Cousineau J, Delvin E, Saint-Cyr C et al (2009) Natriuretic peptide as an adjunctive diagnostic test in the acute phase of Kawasaki disease. Pediatr Cardiol 30:810–817PubMedCrossRef Dahdah N, Siles A, Fournier A, Cousineau J, Delvin E, Saint-Cyr C et al (2009) Natriuretic peptide as an adjunctive diagnostic test in the acute phase of Kawasaki disease. Pediatr Cardiol 30:810–817PubMedCrossRef
4.
Zurück zum Zitat Elaine AR, Kathleen EC, Stanford TS (1995) Kawasaki disease in infants less than one year of age. J Pediatr 126:524–529CrossRef Elaine AR, Kathleen EC, Stanford TS (1995) Kawasaki disease in infants less than one year of age. J Pediatr 126:524–529CrossRef
5.
Zurück zum Zitat Hsiao JY, Chen MR, Huang FU, Kao HA, Sung TC (1998) Clinical analysis of Kawasaki disease in infants below 6 months of age. Acta Paediatr Sin 29:318–323 Hsiao JY, Chen MR, Huang FU, Kao HA, Sung TC (1998) Clinical analysis of Kawasaki disease in infants below 6 months of age. Acta Paediatr Sin 29:318–323
6.
Zurück zum Zitat Kawamura T, Wago M, Kawaguchi H, Tahara M, Yuge M (2000) Plasma brain natriuretic peptide concentrations in patients with Kawasaki disease. Pediatr Int 42:241–248PubMedCrossRef Kawamura T, Wago M, Kawaguchi H, Tahara M, Yuge M (2000) Plasma brain natriuretic peptide concentrations in patients with Kawasaki disease. Pediatr Int 42:241–248PubMedCrossRef
7.
Zurück zum Zitat Kim SH, Kim KH, Kim DS (2009) Clinical characteristics of Kawasaki disease according to age at diagnosis. Indian Pediatr 46:580–590 Kim SH, Kim KH, Kim DS (2009) Clinical characteristics of Kawasaki disease according to age at diagnosis. Indian Pediatr 46:580–590
8.
Zurück zum Zitat Lee HJ, Kim HJ, Kim HS, Sohn SJ (2006) NT-pro BNP: a new diagnostic screening tool for Kawasaki disease. Korean J Pediatr 49:539–544CrossRef Lee HJ, Kim HJ, Kim HS, Sohn SJ (2006) NT-pro BNP: a new diagnostic screening tool for Kawasaki disease. Korean J Pediatr 49:539–544CrossRef
9.
Zurück zum Zitat Limbach HG, Lindinger A (1991) Das Kawasaki-Syndrom bei Sauglingen im ersten Lebanshalbjahr. Klin Padiatr 203:133–136PubMedCrossRef Limbach HG, Lindinger A (1991) Das Kawasaki-Syndrom bei Sauglingen im ersten Lebanshalbjahr. Klin Padiatr 203:133–136PubMedCrossRef
10.
Zurück zum Zitat McCrindle B, Li J, Minich L, Colan S, Atz A, Takahashi M et al (2007) Coronary artery involvement in children with Kawasaki disease: risk factors from analysis of serial normalized measurements. Circulation 116:174–179PubMedCrossRef McCrindle B, Li J, Minich L, Colan S, Atz A, Takahashi M et al (2007) Coronary artery involvement in children with Kawasaki disease: risk factors from analysis of serial normalized measurements. Circulation 116:174–179PubMedCrossRef
12.
Zurück zum Zitat Newburger JW, Sanders SP, Burns JC, Parness IA, Beiser AS, Colan SD (1989) Left ventricular contractility and function in Kawasaki syndrome: effect of intravenous gamma-globulin. Circulation 79:1237–1246PubMedCrossRef Newburger JW, Sanders SP, Burns JC, Parness IA, Beiser AS, Colan SD (1989) Left ventricular contractility and function in Kawasaki syndrome: effect of intravenous gamma-globulin. Circulation 79:1237–1246PubMedCrossRef
13.
Zurück zum Zitat Newburger JW, Takahashi M, Gerber MA, Gewitz MH, Tani LY, Burns JC et al (2004) Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young. Am Heart Assoc 114:1708–1733 Newburger JW, Takahashi M, Gerber MA, Gewitz MH, Tani LY, Burns JC et al (2004) Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young. Am Heart Assoc 114:1708–1733
14.
Zurück zum Zitat Nigrovic LiseE, Nigrovic PeterA, Harper MB, Chiang VW (2006) Extreme thrombocytosis predict Kawasaki disease in infants. Clin Pediatr 45:446–452CrossRef Nigrovic LiseE, Nigrovic PeterA, Harper MB, Chiang VW (2006) Extreme thrombocytosis predict Kawasaki disease in infants. Clin Pediatr 45:446–452CrossRef
15.
Zurück zum Zitat Rowley AH, Gonzalez-Crussi F, Shulman ST (1991) Kawasaki syndrome. Curr Probl Pediatr 21:387–405PubMed Rowley AH, Gonzalez-Crussi F, Shulman ST (1991) Kawasaki syndrome. Curr Probl Pediatr 21:387–405PubMed
16.
Zurück zum Zitat Sato YZ, Molkara DP, Daniels LB et al (2011) Cardiovascular biomarkers in acute Kawasaki disease. Int J Cardiol 142:103–110 Sato YZ, Molkara DP, Daniels LB et al (2011) Cardiovascular biomarkers in acute Kawasaki disease. Int J Cardiol 142:103–110
17.
Zurück zum Zitat Selamet Tierney ES, Newburger JW, Graham D, Baker A, Fulton DR, Colan SD (2011) Diastolic function in children with Kawasaki disease. Int J Cardiol 148:309–312PubMedCrossRef Selamet Tierney ES, Newburger JW, Graham D, Baker A, Fulton DR, Colan SD (2011) Diastolic function in children with Kawasaki disease. Int J Cardiol 148:309–312PubMedCrossRef
18.
Zurück zum Zitat Shulman ST, McAuley JB, Pachman LM, Miller ML, Ruschhaupt DG (1987) Risk of coronary abnormalities due to Kawasaki disease in urban area with small Asian population. Am J Dis Child 141:420–425PubMed Shulman ST, McAuley JB, Pachman LM, Miller ML, Ruschhaupt DG (1987) Risk of coronary abnormalities due to Kawasaki disease in urban area with small Asian population. Am J Dis Child 141:420–425PubMed
19.
Zurück zum Zitat Suzuki H, Uemura S, Tone S, Iizuka T, Koike M, Hirayama K et al (1996) Effects of immunoglobulin and gamma-interferon on the production of tumour necrosis factor-alpha and interleukin-1beta by peripheral blood monocytes in the acute phase of Kawasaki disease. Eur J Pediatr 155:291–296PubMedCrossRef Suzuki H, Uemura S, Tone S, Iizuka T, Koike M, Hirayama K et al (1996) Effects of immunoglobulin and gamma-interferon on the production of tumour necrosis factor-alpha and interleukin-1beta by peripheral blood monocytes in the acute phase of Kawasaki disease. Eur J Pediatr 155:291–296PubMedCrossRef
20.
Zurück zum Zitat Takahashi M, Mason W, Lewis AB (1987) Regression of coronary aneurysms in patients with Kawasaki syndrome. Circulation 75:387–394PubMedCrossRef Takahashi M, Mason W, Lewis AB (1987) Regression of coronary aneurysms in patients with Kawasaki syndrome. Circulation 75:387–394PubMedCrossRef
21.
Zurück zum Zitat Takeuchi D, Saji T, Takatsuki S, Fujiwara M (2007) Abnormal tissue Doppler images are associated with elevated plasma brain natriuretic peptide and increased oxidative stress in acute Kawasaki disease. Circ J 71:357–362PubMedCrossRef Takeuchi D, Saji T, Takatsuki S, Fujiwara M (2007) Abnormal tissue Doppler images are associated with elevated plasma brain natriuretic peptide and increased oxidative stress in acute Kawasaki disease. Circ J 71:357–362PubMedCrossRef
22.
Zurück zum Zitat Yellen ES et al (2010) Performance of 2004 American heart association recommendations for treatment of Kawasaki disease. Pediatrics 125:234–241CrossRef Yellen ES et al (2010) Performance of 2004 American heart association recommendations for treatment of Kawasaki disease. Pediatrics 125:234–241CrossRef
Metadaten
Titel
Do Predictors of Incomplete Kawasaki Disease Exist for Infants?
verfasst von
Sol Ji No
Dong Ouk Kim
Kyong Min Choi
Lucy Youngmin Eun
Publikationsdatum
01.02.2013
Verlag
Springer-Verlag
Erschienen in
Pediatric Cardiology / Ausgabe 2/2013
Print ISSN: 0172-0643
Elektronische ISSN: 1432-1971
DOI
https://doi.org/10.1007/s00246-012-0440-3

Weitere Artikel der Ausgabe 2/2013

Pediatric Cardiology 2/2013 Zur Ausgabe

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.